Back
Vireo Growth 10K Form
Sell
32
VREO.CX
Vireo Growth
Last Price:
0.38
Seasonality Move:
11.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VREO.CX News And Ratings
See the #1 stock for the next 7 days that we like better than VREO.CX
VREO.CX Financial Statistics
Sales & Book Value
| Annual Sales: | $118.96M |
|---|---|
| Cash Flow: | $-10.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.06 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.14190 |
|---|---|
| Net Income (TTM): | $-22.92M |
| Gross Margin: | $59.53M |
| Return on Equity: | 0% |
| Return on Assets: | -9.07% |
Vireo Growth Earnings Forecast
Key Vireo Growth Financial Ratios
- The Gross Profit Margin over the past 16 years for VREO.CX is 50.04%.
- The Selling, General & Administrative Expenses for VREO.CX have been equal to 36.73% of Gross Profit Margin.
- The Interest Expense is -122.37% of Operating Income.
- The Net Earning history of VREO.CX is -28.99% of Total Revenues.
- Per Share Earnings over the last 19 years have been positive in 10 years.
Vireo Growth Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | CNSX |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VREO.CX |
| Website: | vireogrowth.com |
Debt
| Debt-to-Equity Ratio: | -5.27 |
|---|---|
| Current Ratio: | 1.12 |
| Quick Ratio: | 0.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VREO.CX Technical Analysis vs Fundamental Analysis
Sell
32
Vireo Growth (VREO.CX)
is a Sell
Is Vireo Growth a Buy or a Sell?
-
Vireo Growth stock is rated a Sell
The current Vireo Growth [VREO.CX] share price is $0.46. The Score for VREO.CX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.